Evidence map›Paper›PMID 40542493›Full record

ArticleMedical science monitor : international medical journal of experimental and clinical research2025

Comparative Analysis of Oxidative Stress Biomarkers in 50 Primary Open-Angle Glaucoma Patients.

Erbil Seven, Serek Tekin

Abstract readComparative Study
In one paragraph

Article in Medical science monitor : international medical journal of experimental and clinical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Erbil SevenDepartment of Ophthalmology, Faculty of Medicine, Van Yuzuncu Yil University, Van, Turkey.ORCID 0000-0001-5629-291X
Serek TekinDepartment of Ophthalmology, Faculty of Medicine, Van Yuzuncu Yil University, Van, Turkey.ORCID 0000-0002-6660-8313

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Glaucoma, a leading cause of irreversible blindness, is associated with increased oxidative stress and impaired antioxidant defense mechanisms. This study compared serum levels of malondialdehyde (MDA), superoxide dismutase (SOD), catalase (CAT), and reduced glutathione (GSH) in 50 patients with primary open-angle glaucoma (POAG) and 52 healthy controls. MATERIAL AND METHODS Fifty patients in the POAG group and 52 age- and sex-matched individuals in the control group were included in the study. SOD activity was evaluated using the optical density of the blue formazan dye formed at 560 nm due to the interaction of nitroblue tetrazolium with xanthine and superoxide radicals generated by xanthine oxidase. CAT activity in serum was assessed using hydrogen peroxide and phosphate buffer solution. Measurement of GSH levels was performed using a phosphate buffer and DTNB (Ellman's reagent) solution. MDA levels were quantified by measuring the colored complex formed with thiobarbituric acid. All biomarkers were measured using spectrophotometric methods. RESULTS The results indicated significantly higher serum MDA levels (P<0.001) and CAT levels (P<0.001), along with lower SOD levels (P<0.001) and GSH levels (P<0.001) in patients with POAG compared to the controls. CONCLUSIONS These findings suggest that POAG patients experience increased oxidative stress and have an insufficient antioxidant defense system. The imbalance in the oxidant-antioxidant equilibrium in POAG patients suggests a role of oxidative stress in pathogenesis of the disease. Evaluating serum levels of these biomarkers could be valuable for diagnosing and treating POAG.

Indexed as

BiomarkersGlaucoma, Open-AngleOxidative StressAdultAgedAntioxidantsCase-Control StudiesCatalaseFemaleGlutathioneHumansMaleMalondialdehydeMiddle AgedSuperoxide DismutaseAntioxidantsBiomarkersCatalaseGlutathioneMalondialdehydeSuperoxide Dismutase

Identifiers

PMID40542493
PMCPMC12188943

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.